Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1813 to 1862 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1813\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 4 (ec 2.7.1.-) (map kinase kinase 4) (jnk activating kinase 1) (c-jun n- terminal kinase kinase 1) (jnkk) (sapk/erk kinase 1) (sek1). [source:swissprot;acc:p45985]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5866.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6245.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06464\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1814\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-beta (hsp 84) (hsp 90). [source:swissprot;acc:p08238]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5733.71\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6104.26\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06463\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1815\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctional adhesion molecule 1 precursor (jam) (platelet adhesion molecule 1) (pam-1) (platelet f11 receptor). [source:swissprot;acc:q9y624]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6104.77\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6498.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1816\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
potassium channel modulatory factor 1; potassium channel modulatory factor; differentially expressed in branching tubulogenesis 91; zinc finger, zz domain containing 1. [source:refseq;acc:nm\_020122]\vspace{3pt}}&\multirow{17}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}}&\multirow{17}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}}&\multirow{17}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1817\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 23, member 1 (sodium-dependent vitamin c transporter 1) (hsvct1) (na(+)/l-ascorbic acid transporter 1) (yolk sac permease-like molecule 3). [source:swissprot;acc:q9uhi7]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1818\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a3 (hnrnp a3) (d10s102). [source:swissprot;acc:p51991]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1819\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 4. [source:swissprot;acc:p18085]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1820\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1821\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shc transforming protein. [source:swissprot;acc:p29353]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1822\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 289, id1 regulated; likely ortholog of mouse zfp289. [source:refseq;acc:nm\_032389]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1823\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuronal shc. [source:refseq;acc:nm\_016848]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1824\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 1. [source:swissprot;acc:p32889]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1825\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein a1 (helix-destabilizing protein) (single-strand binding protein) (hnrnp core protein a1). [source:swissprot;acc:p09651]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1826\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor 3. [source:swissprot;acc:p16587]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1827\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein sck (fragment). [source:swissprot;acc:p98077]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1828\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoproteins a2/b1 (hnrnp a2 / hnrnp b1). [source:swissprot;acc:p22626]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1829\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ovarian carcinoma immunoreactive antigen. [source:refseq;acc:nm\_017830]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1830\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp-ribosylation factor gtpase-activating protein 3 (arf gap 3). [source:swissprot;acc:q9np61]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1831\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 23, member 2 (sodium-dependent vitamin c transporter 2) (hsvct2) (na(+)/l-ascorbic acid transporter 2) (yolk sac permease-like molecule 2) (nucleobase transporter-like 1 protein). [source:swissprot;acc:q9ugh3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1832\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dual specificity mitogen-activated protein kinase kinase 7 (ec 2.7.1.-) (map kinase kinase 7) (mapkk 7) (mapk/erk kinase 7) (jnk activating kinase 2) (c-jun n-terminal kinase kinase 2) (jnk kinase 2) (jnkk 2). [source:swissprot;acc:o14733]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1833\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
5-formyltetrahydrofolate cyclo-ligase (ec 6.3.3.2) (5,10-methenyl- tetrahydrofolate synthetase) (methenyl-thf synthetase) (mthfs). [source:swissprot;acc:p49914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6175.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6572.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06439\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1834\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l11. [source:swissprot;acc:p39026]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3593.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3375.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06437\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1835\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription elongation factor a protein 2 (transcription elongation factor s-ii protein 2) (testis-specific s-ii) (transcription elongation factor tfiis.l). [source:swissprot;acc:q15560]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5019.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5342.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06436\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1836\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription elongation factor a protein 1 (transcription elongation factor s-ii protein 1) (transcription elongation factor tfiis.o). [source:swissprot;acc:p23193]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1837\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad17 homolog isoform 1; rad17-like protein; cell cycle checkpoint protein (rad17); rf-c activator 1 homolog. [source:refseq;acc:nm\_002873]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5739.49\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6108.72\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06433\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1838\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 70 kda subunit (lupus ku autoantigen protein p70) (ku70) (70 kda subunit of ku antigen) (thyroid-lupus autoantigen) (tlaa) (ctc box binding factor 75 kda subunit) (ctcbf) (ctc75). [source:swissprot;acc:p12956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1839\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-dependent dna helicase ii, 80 kda subunit (lupus ku autoantigen protein p86) (ku86) (ku80) (86 kda subunit of ku antigen) (thyroid- lupus autoantigen) (tlaa) (ctc box binding factor 85 kda subunit) (ctcbf) (ctc85) (nuclear factor iv) (dna-repair protein xrcc5). [source:swissprot;acc:p13010]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1840\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase a (ec 2.7.7.15) (phosphorylcholine transferase a) (ctp:phosphocholine cytidylyltransferase a) (ct a) (cct a) (cct-alpha). [source:swissprot;acc:p49585]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3591.95\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3375.34\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06417\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1841\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
fad synthetase. [source:refseq;acc:nm\_025207]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1842\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 2 (paps synthethase 2) (papss 2) (sulfurylase kinase 2) (sk2) (sk 2) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o95340]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1843\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ligatin (hepatocellular carcinoma-associated antigen 56). [source:swissprot;acc:p41214]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1844\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthethase 1 (paps synthethase 1) (papss 1) (sulfurylase kinase 1) (sk1) (sk 1) [includes: sulfate adenylyltransferase (ec 2.7.7.4) (sulfate adenylate transferase) (sat) (atp-sulfurylase); adenylylsulfate kinase (ec 2.7.1.25) (adenylylsulfate 3'-phosphotransferase) (aps kinase) (adenosine-5'-phosphosulfate 3'-phosphotransferase) (3'- phosphoadenosine-5'-phosphosulfate synthetase)]. [source:swissprot;acc:o43252]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1845\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadph-cytochrome p450 reductase (ec 1.6.2.4) (cpr) (p450r). [source:swissprot;acc:p16435]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1846\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cholinephosphate cytidylyltransferase b (ec 2.7.7.15) (phosphorylcholine transferase b) (ctp:phosphocholine cytidylyltransferase b) (ct b) (cct b) (cct-beta). [source:swissprot;acc:q9y5k3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1847\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glutamine synthetase (ec 6.3.1.2) (glutamate--ammonia ligase). [source:swissprot;acc:p15104]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6215.55\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6613.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06402\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1848\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heat shock protein hsp 90-alpha (hsp 86). [source:swissprot;acc:p07900]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5746.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6113.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.064\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1849\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginase ii, mitochondrial precursor (ec 3.5.3.1) (non-hepatic arginase) (kidney-type arginase). [source:swissprot;acc:p78540]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6267.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6668.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06394\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1850\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase c binding protein 1 (rack7) (cutaneous t-cell lymphoma associated antigen se14-3) (ctcl tumor antigen se14-3) (zinc finger mynd domain containing protein 8). [source:swissprot;acc:q9ulu4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6158.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6551.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06387\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1851\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
adenovirus 5 e1a-binding protein (bs69 protein). [source:swissprot;acc:q15326]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6156.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6549.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0638\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1852\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
arginase 1 (ec 3.5.3.1) (liver-type arginase). [source:swissprot;acc:p05089]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6271.17\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6670.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06375\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1853\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 9.2. [source:refseq;acc:nm\_031961]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6076.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6463.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06368\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1854\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-10; keratin associated protein 4.10. [source:refseq;acc:nm\_033060]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6076.66\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0636\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1855\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-2; keratin associated protein 4.2. [source:refseq;acc:nm\_033062]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1856\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.3 (fragment). [source:sptrembl;acc:q9byr4]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1857\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 2-4; keratin associated protein 2.4. [source:refseq;acc:nm\_033184]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.15\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1858\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-14; keratin associated protein 4.14. [source:refseq;acc:nm\_033059]\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1859\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4.9 (fragment). [source:sptrembl;acc:q9byq8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
1860\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 4-12; keratin associated protein 4.12. [source:refseq;acc:nm\_031854]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1861\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
keratin associated protein 1.5. [source:refseq;acc:nm\_031957]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.14\vspace{3pt}}&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1862\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
star-related lipid transfer protein 6 (stard6) (start domain- containing protein 6). [source:swissprot;acc:p59095]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6463.13\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/